ProfileGDS4718 / 203889_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 43% 79% 31% 42% 36% 30% 50% 42% 43% 66% 43% 37% 27% 47% 81% 58% 39% 78% 62% 42% 65% 60% 49% 51% 45% 48% 43% 28% 50% 82% 52% 41% 42% 52% 69% 63% 39% 37% 81% 50% 63% 78% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1321843
GSM549102patient 115, normal, homogenized [OPG study]5.177843
GSM549104patient 119, normal, homogenized [OPG study]7.8261679
GSM549108patient 138, normal, homogenized [OPG study]4.6114431
GSM549119patient 077, normal, homogenized [OPG study]5.0793942
GSM549133patient 032, cancer, homogenized [OPG study]4.7633836
GSM549139patient 042, cancer, homogenized [OPG study]4.526330
GSM549099patient 107, normal, homogenized [OPG study]5.5216450
GSM549109patient 139, normal, homogenized [OPG study]5.1115542
GSM549110patient 046, normal, homogenized [OPG study]5.1600643
GSM549114patient 063, normal, homogenized [OPG study]6.5474666
GSM549122patient 082, normal, homogenized [OPG study]5.1629743
GSM549134patient 033, cancer, homogenized [OPG study]4.8279737
GSM549136patient 036, cancer, homogenized [OPG study]4.3457527
GSM549140patient 044, cancer, homogenized [OPG study]5.3319847
GSM549111patient 047, normal, homogenized [OPG study]8.0141781
GSM549113patient 057, normal, homogenized [OPG study]5.9756358
GSM549132patient 031, cancer, homogenized [OPG study]4.9103439
GSM549137patient 038, cancer, homogenized [OPG study]7.7032678
GSM549142patient 047, cancer, homogenized [OPG study]6.3621462
GSM549100patient 110, normal, homogenized [OPG study]5.1061942
GSM549107patient 135, normal, homogenized [OPG study]6.4411865
GSM549115patient 068, normal, homogenized [OPG study]6.0834660
GSM549116patient 072, normal, homogenized [OPG study]5.4289749
GSM549120patient 078, normal, homogenized [OPG study]5.5653551
GSM549131patient 030, cancer, homogenized [OPG study]5.2070945
GSM549118patient 074, normal, homogenized [OPG study]5.3726748
GSM549129patient 027, cancer, homogenized [OPG study]5.1430543
GSM549123patient 088, normal, homogenized [OPG study]4.4308328
GSM549124patient 006, cancer, homogenized [OPG study]5.5587950
GSM549126patient 015, cancer, homogenized [OPG study]8.0261482
GSM549128patient 025, cancer, homogenized [OPG study]5.6076152
GSM549103patient 117, normal, homogenized [OPG study]5.0946841
GSM549117patient 073, normal, homogenized [OPG study]5.068542
GSM549138patient 041, cancer, homogenized [OPG study]5.614152
GSM549141patient 045, cancer, homogenized [OPG study]6.8808869
GSM549130patient 028, cancer, homogenized [OPG study]6.3082463
GSM549101patient 111, normal, homogenized [OPG study]4.9784939
GSM549105patient 128, normal, homogenized [OPG study]4.8647137
GSM549106patient 134, normal, homogenized [OPG study]8.0902281
GSM549112patient 048, normal, homogenized [OPG study]5.5139450
GSM549125patient 011, cancer, homogenized [OPG study]6.3542663
GSM549127patient 024, cancer, homogenized [OPG study]7.7466678
GSM549135patient 035, cancer, homogenized [OPG study]7.7891478